Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects

NCT01517399 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: tivantinib
DRUG: omeprazole
DRUG: s-warfarin
DRUG: caffeine
DIETARY_SUPPLEMENT: vitamin K
DRUG: digoxin
DRUG: midazolam

Sponsor

Daiichi Sankyo

Collaborators

[object Object]